FR2352790A1 - Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant - Google Patents

Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant

Info

Publication number
FR2352790A1
FR2352790A1 FR7715966A FR7715966A FR2352790A1 FR 2352790 A1 FR2352790 A1 FR 2352790A1 FR 7715966 A FR7715966 A FR 7715966A FR 7715966 A FR7715966 A FR 7715966A FR 2352790 A1 FR2352790 A1 FR 2352790A1
Authority
FR
France
Prior art keywords
monosubstituents
benzamides
acyl
amino
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7715966A
Other languages
English (en)
French (fr)
Other versions
FR2352790B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of FR2352790A1 publication Critical patent/FR2352790A1/fr
Application granted granted Critical
Publication of FR2352790B1 publication Critical patent/FR2352790B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR7715966A 1976-05-26 1977-05-25 Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant Granted FR2352790A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/690,300 US4044147A (en) 1976-05-26 1976-05-26 N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents

Publications (2)

Publication Number Publication Date
FR2352790A1 true FR2352790A1 (fr) 1977-12-23
FR2352790B1 FR2352790B1 (enExample) 1980-11-14

Family

ID=24771930

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7715966A Granted FR2352790A1 (fr) 1976-05-26 1977-05-25 Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant

Country Status (10)

Country Link
US (1) US4044147A (enExample)
JP (1) JPS52144640A (enExample)
BE (1) BE855022A (enExample)
DE (1) DE2723051C3 (enExample)
DK (1) DK223177A (enExample)
FR (1) FR2352790A1 (enExample)
GB (1) GB1539862A (enExample)
IE (1) IE44499B1 (enExample)
LU (1) LU77403A1 (enExample)
NL (1) NL170135C (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2600513A1 (de) * 1976-01-08 1977-07-28 Hoechst Ag Acylamino(alkyl)benzolderivate und verfahren zu ihrer herstellung
US4500714A (en) * 1981-10-15 1985-02-19 Chugai Seiyaku Kabushiki Kaisha 3-Substituted-ureido-N-pyridyl benzamides
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
US5643965A (en) * 1995-04-03 1997-07-01 Centaur Pharmaceuticals, Inc. Aminobenzamide compounds for the treatment of neurodegenerative disorders
US5658953A (en) * 1995-04-03 1997-08-19 Centaur Pharmaceuticals, Inc. Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US5955506A (en) * 1996-04-03 1999-09-21 Centaur Pharmaceuticals, Inc. Benzamides for neurodegenerative disorder treatment
WO2001017953A1 (en) * 1999-09-08 2001-03-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
EP1360173A2 (en) 2001-01-25 2003-11-12 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
WO2006137080A1 (en) * 2005-06-22 2006-12-28 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe
US20070049748A1 (en) * 2005-08-26 2007-03-01 Uppala Venkata Bhaskara R Preparation of ezetimibe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212268C3 (de) * 1971-03-15 1979-09-13 Sumitomo Chemical Co., Ltd., Osaka (Japan) N-Halogenacetylanilinoessigsäureester, Verfahren zu deren Herstellung und diese enthaltende herbicide Massen
JPS50157336A (enExample) * 1974-06-11 1975-12-19

Also Published As

Publication number Publication date
DK223177A (da) 1977-11-27
NL170135B (nl) 1982-05-03
DE2723051B2 (de) 1979-11-22
DE2723051A1 (de) 1977-12-01
IE44499L (en) 1977-11-26
IE44499B1 (en) 1981-12-16
LU77403A1 (enExample) 1979-01-19
JPS52144640A (en) 1977-12-02
JPS574626B2 (enExample) 1982-01-27
GB1539862A (en) 1979-02-07
NL170135C (nl) 1982-10-01
NL7705565A (nl) 1977-11-29
US4044147A (en) 1977-08-23
FR2352790B1 (enExample) 1980-11-14
DE2723051C3 (de) 1980-07-31
BE855022A (fr) 1977-11-25

Similar Documents

Publication Publication Date Title
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE876732A (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
BE869793A (fr) Nouveaux derives d'amines et amidines de glycerols et propanediols et medicaments les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
FR2336129A1 (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
BE855022A (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
BE858608A (fr) Melanges contenant des polydiorganosiloxanes et leur preparation
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
FR2450814B1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
BE863620A (fr) Nouveaux derives 4"-amines d'oleandomycine et medicaments les contenant
BE858147A (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
FR2276292A1 (fr) Melanges liquides d'azonitriles et leur preparation
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE885393A (fr) Nouveaux amino-2 benzoyl-3 phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions therapeutiques et formes pharmaceutiques les contenant
BE883749A (fr) Beta-octamolybdate d'ammelinium et compositions le contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
BE853155A (fr) Nouveaux derives de sucres amines et medicament les contenant
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse